Title : Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.

Pub. Date : 2016 Jan

PMID : 26595724






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In the base-case analysis, among patients receiving 8 or 12 weeks of sofosbuvir-ledipasvir treatment, treating all fibrosis stages compared with treating stages F3 and F4 adds 0.73 QALYs and $28,899, for an ICER of $39,475 per QALY gained. Sofosbuvir cAMP responsive element modulator Homo sapiens
2 A 46% reduction in cost of sofosbuvir-ledipasvir therapy decreases the ICER for treating at all fibrosis stages by 48%. Sofosbuvir cAMP responsive element modulator Homo sapiens